Actinium Pharmaceuticals, Inc. (ATNM) stock price moved 5.83% away from 20-Days Simple Moving Average, -7.80% from 50-Days Simple Moving Average and separated -19.43% from 200 Days Simple Moving Average. Actinium Pharmaceuticals, Inc. (ATNM) reported gain 1.70% in recent buying and selling session with closing price of $ 0.44. The stock’s traded 0.22 million shares in session while it holds an average volume of 0.85 million shares. The ATNM switched 33.13% away from its 52 week minimum and distanced -48.86% from its 52 week peak. The volatility change in the previous week has observed by 6.95% and experienced of 7.78% change in the last month.
The short ratio in the company’s stock is documented at 2.27 and the short float is around of 1.70%. Beta factor, which measures the riskiness of the security, was registered at 2.20. The Company kept a record of 113.80 million floated shares and 113.80 million shares outstanding. The average true range of the stock is observed at 0.04 and the relative strength index of the stock is recorded at 47.84.
Actinium Pharmaceuticals, Inc. (ATNM) Stock Profitability Levels:
The company made Return on equity of -139.90% in last 12 months period. Return on assets ratio of the Company was -106.20%.
For the past 5 years, The Company’s EPS growth has been nearly 44.50%. Analyst established EPS growth expected to grow of 20.60% for this year and EPS growth for next year is likely to attain at 9.10%.
Looking about the past performance history, the company jumped -3.81% for the last five trades and expanded 0.55% in one month period. The stock deteriorated -42.55% during the past three month period and discounted -39.41% in half year. During the yearly overview it downgraded -37.53% and shown 14.32% year to date performance.